113 related articles for article (PubMed ID: 223355)
21. The effect of chronic low-dose infusion of ACTH (1-24) on renin, renin-substrate, aldosterone and other corticosteroids in sodium replete and deplete man.
Fuchs-Hammoser R; Schweiger M; Oelkers W
Acta Endocrinol (Copenh); 1980 Oct; 95(2):198-206. PubMed ID: 6254307
[No Abstract] [Full Text] [Related]
22. Dopamine inhibits the aldosterone response to upright posture.
Malchoff CD; Hughes J; Sen S; Jackson S; Carey RM
J Clin Endocrinol Metab; 1986 Jul; 63(1):197-201. PubMed ID: 3519647
[TBL] [Abstract][Full Text] [Related]
23. The renin-angiotensin-aldosterone axis in patients with nontumoral [corrected] hyperprolactinemia.
Mediskou P; Yavropoulou MP; Kotsa K; Tsekmekidou X; Psarakou-Gotzamani A; Papazisi A; Chlorou A; Yovos JG
Clin Endocrinol (Oxf); 2011 Mar; 74(3):306-11. PubMed ID: 21114511
[TBL] [Abstract][Full Text] [Related]
24. Changes in plasma aldosterone following the administration of various combinations of stimuli.
Gaillard RC; Riondel A; Merkelbach U; Vallotton MB
Acta Endocrinol (Copenh); 1979 Oct; 92(2):309-18. PubMed ID: 227211
[No Abstract] [Full Text] [Related]
25. Dopaminergic modulation of corticosteroid responses to angiotensin II in man.
Sowers JR; Beck FW
Clin Exp Hypertens A; 1983; 5(5):651-64. PubMed ID: 6309435
[TBL] [Abstract][Full Text] [Related]
26. Aldosterone suppression with dopamine infusion in low-renin hypertension.
Holland OB; Thomas C; Brown H; Schindewolf D; Hillier Y; Gomez-Sanchez C
J Clin Invest; 1983 Sep; 72(3):754-66. PubMed ID: 6309909
[TBL] [Abstract][Full Text] [Related]
27. Aldosterone synthase gene variation and adrenocortical response to sodium status, angiotensin II and ACTH in normal male subjects.
Kennon B; Ingram MC; Friel EC; Anderson NH; MacKenzie SM; Davies E; Shakerdi L; Wallace AM; Fraser R; Connell JM
Clin Endocrinol (Oxf); 2004 Aug; 61(2):174-81. PubMed ID: 15272911
[TBL] [Abstract][Full Text] [Related]
28. Role of the renin-angiotensin-aldosterone system in the regulation of plasma potassium in chronic renal disease.
Weidmann P; Maxwell MH; Rowe P; Winer R; Massry SG
Nephron; 1975; 15(1):35-49. PubMed ID: 165438
[TBL] [Abstract][Full Text] [Related]
29. Aldosterone regulation in essential hypertension: altered adrenal responsiveness to angiotensin II.
Williams GH; Dluhy RG; Moore TJ
Mayo Clin Proc; 1977 May; 52(5):312-6. PubMed ID: 870773
[TBL] [Abstract][Full Text] [Related]
30. Prolactin and the renin-aldosterone axis in human pregnancy.
Yuen BH; Korn GW
Am J Obstet Gynecol; 1980 Dec; 138(7 Pt 1):738-40. PubMed ID: 7004189
[TBL] [Abstract][Full Text] [Related]
31. [Effect of furosemide and ACTH on plasma renin, aldosterone and cortisol levels in normal man].
Cénac A; London A; Ménard J; Corvol P
Ann Endocrinol (Paris); 1975; 36(3):153-62. PubMed ID: 172005
[TBL] [Abstract][Full Text] [Related]
32. Interrelations between age and plasma renin, aldosterone and cortisol, urinary catecholamines, and the body sodium/volume state in normal man.
Weidmann P; de Chatel R; Schiffmann A; Bachmann E; Beretta-Piccoli C; Reubi FC; Ziegler WH; Vetter W
Klin Wochenschr; 1977 Aug; 55(15):725-33. PubMed ID: 895008
[TBL] [Abstract][Full Text] [Related]
33. [Studies of the effect of bromocriptine on the serum prolactin, aldosterone and cortisol levels and plasma renin activity in patients with essential hypertension].
Hudziak G; Kuska J
Pol Arch Med Wewn; 1988 Jul; 80(1):9-16. PubMed ID: 3078204
[No Abstract] [Full Text] [Related]
34. Effect of propranolol therapy on aldosterone responses to angiotensin II and adrenocorticotropic hormone in essential hypertension.
Golub MS; Tuck ML; Fittingoff DB
Clin Sci (Lond); 1981 Jul; 61(1):107-10. PubMed ID: 6265141
[TBL] [Abstract][Full Text] [Related]
35. Dopaminergic modulation of pressor and hormonal responses in essential hypertension.
Sowers JR; Golub MS; Berger ME; Whitfield LA
Hypertension; 1982; 4(3):424-30. PubMed ID: 6279498
[TBL] [Abstract][Full Text] [Related]
36. Stimulation of growth hormone and corticotropin release by angiotensin II in man.
degli Uberti EC; Trasforini G; Margutti A; Rossi R; Ambrosio MR; Pansini R
Metabolism; 1990 Oct; 39(10):1063-7. PubMed ID: 2170820
[TBL] [Abstract][Full Text] [Related]
37. Unresponsiveness of plasma mineralocorticoids to angiotensin II in diabetic patients with asymptomatic normoreninemic hypoaldosteronism.
Kigoshi T; Morimoto S; Uchida K; Hosojima H; Yamamoto I; Imaizumi N; Azukizawa S
J Lab Clin Med; 1985 Feb; 105(2):195-200. PubMed ID: 2982980
[TBL] [Abstract][Full Text] [Related]
38. The dopamine agonist bromocriptine induces hypotension by venous and arteriolar dilation.
Johns DW; Ayers CR; Carey RM
J Cardiovasc Pharmacol; 1984; 6(4):582-7. PubMed ID: 6206310
[TBL] [Abstract][Full Text] [Related]
39. Effects of acute administration of zetidoline, a new antidopaminergic drug, on plasma prolactin and aldosterone levels in man.
Barbieri C; Parodi M; Bruno S; Bertassi F; Benaglia D; Moser P; Meroni R; Dubini A
Eur J Clin Pharmacol; 1984; 26(1):29-32. PubMed ID: 6143669
[TBL] [Abstract][Full Text] [Related]
40. Moderate weight loss reduces renin and aldosterone but does not influence basal or stimulated pituitary-adrenal axis function.
Ho JT; Keogh JB; Bornstein SR; Ehrhart-Bornstein M; Lewis JG; Clifton PM; Torpy DJ
Horm Metab Res; 2007 Sep; 39(9):694-9. PubMed ID: 17846979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
